Carroll Financial Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$6K Hold
118
﹤0.01% 1287
2021
Q3
$7K Hold
118
﹤0.01% 1310
2021
Q2
$7K Hold
118
﹤0.01% 1366
2021
Q1
$7K Hold
118
﹤0.01% 1294
2020
Q4
$7K Hold
118
﹤0.01% 1186
2020
Q3
$6K Buy
118
+107
+973% +$5.49K ﹤0.01% 1148
2020
Q2
$0 Hold
11
﹤0.01% 1557
2020
Q1
$0 Hold
11
﹤0.01% 1503
2019
Q4
$0 Hold
11
﹤0.01% 1565
2019
Q3
$0 Hold
11
﹤0.01% 1561
2019
Q2
$0 Sell
11
-29
-73% -$1.41K ﹤0.01% 1599
2019
Q1
$1K Buy
40
+11
+38% +$557 ﹤0.01% 1293
2018
Q4
$1K Hold
29
﹤0.01% 1221
2018
Q3
$1K Buy
+29
New +$1.76K ﹤0.01% 1232

Other funds holding EHC

Carroll Financial Associates's EHC Position: Q4 2021 in Review

Carroll Financial Associates held its Encompass Health (EHC) position steady in Q4 2021 at 118 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

Carroll Financial Associates first reported a position in EHC in Q3 2018 and has held it in 14 quarters since. The position peaked at $7K in Q3 2021. 409 funds tracked by Wall St. Rank hold EHC as of Q4 2021.

  • Carroll Financial Associates held 118 shares of Encompass Health worth $6K as of Q4 2021.
  • Carroll Financial Associates left its Encompass Health share count unchanged in Q4 2021.
  • Encompass Health made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1287 holding.
  • Carroll Financial Associates first reported a position in Encompass Health in Q3 2018 and has held it in 14 quarters since.
  • Carroll Financial Associates's Encompass Health position peaked at $7K in Q3 2021.
  • 409 funds tracked by Wall St. Rank held Encompass Health as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.